HES5 and neoplasm: The tumour-specific methylation changes at the HES5 promoter were consistent within and between cases and comparable with the hypermethylation observed at the GSTP1 gene (Fig. 1d and e), which is invariably silenced in prostate cancer and has been extensively studied (Lee et al. 1994).